Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 3 April 2017, Mr Peter George, Chairman of the Company, bought 100,000 ordinary shares of 1p each in the Company (“Share(s)”) at a price of 190p per Share. Following this transaction, […]
Ergomed, a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, announces that on 3 April 2017, Mr Peter George, Chairman of the Company, bought 100,000 ordinary shares of 1p each in the Company (“Share(s)”) at a price of 190p per Share. Following this transaction, Mr Peter George holds 231,250 (0.6 per cent. of the Company’s issued share capital).
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name | Peter George | |
| 2 | Reason for the notification | ||
| a) | Position/status | Chairman | |
| b) | Initial notification /Amendment | Initial Notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Ergomed Plc | |
| b) | Legal Entity Identifier | 213800BVS8I9VMC1AP84 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 1 pence each
GB00BN7ZCY67 |
|
| b) | Nature of the transaction | Purchase of shares | |
| c) | Currency | GBP | |
| d) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 190p | 100,000 | ||
| e) | Aggregated information
– Aggregated volume – Price – Aggregated total |
100,000 190p £190,000 |
|
| f) | Date of the transaction | 03 April 2017 | |
| g) | Place of the transaction | London Stock Exchange, AIM | |
Enquiries:
| Ergomed Plc | Tel: +44 (0) 1483 503205 |
| Miroslav Reljanovic (Chief Executive Officer) | |
| Stephen Stamp (Chief Financial Officer) | |
| Numis Securities (Nominated Advisor and Broker) | Tel: +44 (0) 20 7260 1000 |
| Michael Meade / Freddie Barnfield (Nominated Adviser) | |
| James Black (Joint Broker) | |
| Stifel Nicolaus Europe Limited | Tel: +44 (0) 20 7710 7600 |
| Jonathan Senior (Joint Broker)
|
|
| FTI Consulting (Financial PR) | Tel: +44 (0) 20 3727 1000 |
| Simon Conway / Mo Noonan / Natalie Garland-Collins | |
| MC-Services – for Continental European enquiries | Tel: +49 211 52925222 |
| Anne Hennecke |
